Professor of Surgery Dmitry V. Garbuzenko, MD

---

Date of birth: 29 June 1962
The birthplace: village Pereyaslavka of Khabarovsky kray, Russia
Address: POBox 12317, Chelyabinsk, 454080, Russia
E-mail (1): garb@inbox.ru
E-mail (2): garbuzenkodv@gmail.com
Telegram/Viber/WhatsApp: +79097459826
Marital status: Married
Nationality: Russian
Education:

• 1979-1985: a student in Chelyabinsk State Medical Institute.
• 1985-1987: Post-graduate student, the Department of Hospital Surgery, Chelyabinsk State Medical Institute.
• 1987-1990: PhD student of the Department of Hospital Surgery, Chelyabinsk State Medical Institute.

Employment:

• 1991 - 2003: Assistant Professor of the Department of Faculty Surgery, Chelyabinsk State Medical Academy.
• 2003 - 2010: Associate Professor of the Department of Faculty Surgery, Chelyabinsk State Medical Academy.
• 2010 - to present: Professor of the Department of Faculty Surgery, South Ural State Medical University.

Academic title: Professor
Qualifications: Surgeon of the highest category
Work Experience: My practical activities are associated with emergency abdominal surgery. I am able to perform all kinds of operations on the abdominal organs and specialize in surgery of the liver, biliary tract, and pancreas. I have the extensive experience in experimental work on the problem of portal hypertension (modeling, treatment).

Skills: Microsoft Office (Word, Excel)
Languages: native speaker of Russian, working knowledge of English.

Scientific achievements:

• 1991: Defended a candidate’s dissertation (PhD) on subject: "Influence of a small bowel resection on the clinical course of portal hypertension".
• 2008: Defended a doctoral dissertation on subject: "The effect of the laser revascularization of the cirrhotic liver on portal hypertension".

h-index:

• Russian Science Citation Index - 22.
• Web of Science - 9.
• Scopus - 10.

Sphere of my Research Interests includes clinical and pathological problems associated with liver cirrhosis and portal hypertension.
I am the member of the Russian Society of Surgeons, the Russian Gastroenterological Association, the Hepato-Pancreato-Biliary Association of Commonwealth of Independent States, the Russian Academy of Natural Sciences.
I am an author of more than 212 publications (some of them are listed below), 7 inventions, 3 monographs:

• Gastroesophageal variceal hemorrhage in cirrhotic patients: pathogenesis, prophylactic, treatment. - Chelyabinsk, Russia: "Eastern Gate", 2004 (in Russian).
• Selected lectures in emergency abdominal surgery. - Saarbrücken, Germany: LAP LAMBERT Academic Publishing GmbH& Co., 2012 (in Russian).
• Angiogenesis: The new aim for targeted therapy of portal hypertension for liver cirrhosis. - M.: Nauka, 2020 (in Russian).
  

Co-author of the monograph:

• Anti-Angiogenesis Drug Discovery and Development. Vol. 4. Ed. Atta-ur-Rahman and M. Iqbal Choudhary. - Sharjah, UAE: Bentham Science Publishers, 2019. - 228 p.

The editor of the books:

• Portal Hypertension - Causes and Complications. Ed. D. Garbuzenko. - Rijeka, Croatia: InTech, 2012. - 144 p.
• Actual Problems of Emergency Abdominal Surgery. Ed. D. Garbuzenko. - Rijeka, Croatia: InTech, 2016. - 208 p.
• Current Issues in the Diagnostics and Treatment of Acute Appendicitis. Ed. D. Garbuzenko. - London, United Kingdom: InTech, 2018. - 92 p.
• Pancreatitis. Ed. D. Garbuzenko. - London, United Kingdom: InTech, 2019. - 82 p.
• Intestinal Obstruction. Ed. D. Garbuzenko. - London, United Kingdom: InTech, 2020. - 82 p.
• Abdominal Trauma - New Solutions to Old Problems. Ed. D. Garbuzenko. - London, United Kingdom: InTech, 2023. - 112 p.
  

Co-author of the clinical guidelines: Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association.

Online Academic Editor of the Management Team of the Baishideng Publishing Group.

Editorial board member:

• World Journal of Hepatology ^CERTIFICATE (Associate Editor).
• International Journal of Medical and Health Research ^CERTIFICATE.  
  

Peer-reviewer:

• World Journal of Gastroenterology.
• World Journal of Clinical Cases.
• World Journal of Transplantation.
• Journal of Digestive Diseases.
• European Medical Journal Hepatology. 
• Journal of International Medical Research.
• American Journal of Case Reports.
• Therapeutics and Clinical Risk Management.
• Medical Science Monitor.
• Hepatoma Research.
• BMJ Case Reports
• Annals of Translational Medicine
  
• Journal of Clinical Pharmacy & Therapeutics.
• Gastroenterology: Medicine & Research.
• JSM Gastroenterology and Hepatology.
  

List of publications:
1. Garbuzenko D.V., Lyannoy K.V. [The effect of the small intestinal resection on the pressure in the portal venous system in experimental portal hypertension]. Klin. Khir. 1990; 71 (11): 24-27. (in Russian) (pdf) (PubMed)
2. Malyshev Yu.I., Red'kin G.A., Garbuzenko D.V. [Results of the small intestinal resection in patients with portal hypertension]. Klin. Khir. 1991; 72 (9): 12-15. (in Russian) (pdf) (PubMed)
3. Garbuzenko D.V. [Phlegmon of the hernial sac after surgery for diffuse fibrinous peritonitis]. Klin. Khir. 1993; 74 (6): 66-67. (in Russian) (pdf) (PubMed)
4. Garbuzenko D.V. [Hemodynamic disorder, conditionned by liver cirrhosis]. Klin. Med. (Mosk). 1996; 74 (2): 5-7. (in Russian) (pdf) (PubMed)
5. Garbuzenko D.V., Sen'kova N.N., Bordunovsky V.N. [Method cultivation and transplantation isolated hepatocytes in experiment acute hepatic failure]. Ann. hir. gepatol. 1998; (2) (Suppl): 151. (in Russian)
6. Garbuzenko D.V., Sen'kova N.N. [Intraperitoneal transplantation of microcarrier-attached isolated hepatocytes in experiment]. Ros. gastrojenterol. zh. 1998; (4): 170-171. (in Russian)
7. Garbuzenko D.V., Popov G.K. [Mechanisms of liver regeneration regulation]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2001; 11 (1): 21-25. (in Russian) (pdf)
8. Garbuzenko D.V. [Pathogenesis of portal hypertension at liver cirrhosis]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2002; 12 (5): 23-29. (in Russian) (pdf)
9. Garbuzenko D.V., Marysheva I.V. [Modification of portal blood flow after lazer revascularization cirrhotic liver]. Jeksperimental klinich. gastrojenterol. 2003; (5) (Suppl): 133. (in Russian)
10. Garbuzenko D.V. [Pharmacotherapy in portal hypertension]. Klin. Med. (Mosk).) 2004; 82 (3): 16-20 (in Russian) (pdf) (PubMed) 
11. Garbuzenko D.V. [Portal-hypertensive gastropathy]. Medical Journal of the Russian Federation. 2004; (4): 44-45 (in Russian) (pdf)
12. Garbuzenko D.V. [Prophylaxis of bleedings from varicose esophageal and stomach veins in liver cirrhosis patients ]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2004; 14 (4): 8-13. (in Russian) (pdf)
13. Garbuzenko D.V. [Laser revascularization of the cirrhotic liver as a way of portal hypertension management] Ann. hir. gepatol. 2004; 9 (2) (Suppl): 216. (in Russian) (pdf)
14. Garbuzenko D.V. [Porto-pulmonary hypertension and hepatopulmonary syndrome in patients with hepatic cirrhosis]. Pul'monologija 2006; (1): 103-107. (in Russian) (pdf)
15. Garbuzenko D.V. [The treatment tactics in the bleeding gastric varices]. Annals of HPB surgery. 2007; 12 (1): 96-102 (in Russian) (pdf)
16. Garbuzenko D.V. [Multiorgan hemodynamic disorder, conditionned by liver cirrhosis]. Ter. Arkh. 2007; 79 (2): 73-77. (in Russian) (pdf) (PubMed) 
17. Kovalenko V.L., Abramovskaya N.V., Garbuzenko D.V.  [Morphological characteristic compensatory and adaptation response in the cirrhotic liver after influence of highenergy lazer radiation]. Ural. med. zhurn. 2007; (12): 75-78. (in Russian) (pdf)
18. Garbuzenko D.V. [The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension]. Klin Med (Mosk). 2007; 85 (8): 15-19. (in Russian) (pdf) (PubMed)
19. Garbuzenko D.V. [Mechanisms of compensation of structure and function of the liver at its damage and their practical significance]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2008; 18 (6): 14-21. (in Russian) (pdf)
20. Danilova T.V., Garbuzenko D.V., Mikurov A.A. [Cases of enteropathy, accompanied by uncontrolled bleeding in patients with liver cirrhosis with portal hypertension (morphological study)]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2009; 19 (5) (Suppl 34): 47-47. (in Russian) (pdf)
21. Garbuzenko D.V. [Experimental methods of portal hypertension studying]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2010; 20 (2): 4-12. (in Russian) (pdf)
22. Garbuzenko D.V. [Pathophysiological mechanisms and new directions of therapy of portal hypertension at liver cirrhosis]. Klin. persp. gastrojen. gepatol. 2010; (6): 11-20. (in Russian) (pdf)
23. Mikurov A.A., Garbuzenko D.V. [The comparative analysis of level endotoxemia at patients of the liver cirrhosis with portal hypertension]. Fundamental'nye issledovanija 2011; (6): 126-128. (in Russian) (pdf)
24. Garbuzenko D.V., Mikurov A.A. [The role of endotoxemia in the development of the bleeding esophageal varices in patients with liver cirrhosis]. Medical Journal of the Russian Federation. 2011; (6): 47-49. (in Russian) (pdf)
25. Garbuzenko D., Mikurov A., Smirnov D. The Bacterial Endotoxins Levels in the Blood of Cirrhotic Patients as Predictor of the Risk of Esophageal Varices Bleeding. In: Portal Hypertension - Causes and Complications. Ed. D. Garbuzenko. Rijeka, Croatia: InTech, 2012 p. 85-92. (pdf)
26. Garbuzenko D.V. [Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2012; 22 (2): 36-44. (in Russian) (pdf)
27. Garbuzenko D.V., Mikurov A., Smirnov D. [Bacterial endotoxinemia and the risk of the bleeding esophageal varices in patients with liver cirrhosis]. Klin. Med. (Mosk). 2012; 90 (7): 48-51. (in Russian) (pdf) (PubMed)
28. Garbuzenko D.V. [The mechanisms of adaptation of the vascular bed to hemodynamic changes in portal hypertension]. Vestn. Ross. Akad. Med. Nauk.  2013; (1): 52-57. (in Russian) (pdf) (PubMed)
29. Garbuzenko D.V. [The risk factors of extrahepatic abdominal operations in patients with liver cirrhosis]. Khirurgiia (Mosk). 2013; (8): 86-92. (in Russian) (pdf) (PubMed)
30. Garbuzenko D.V. [Portal biliopathy]. Vrach 2014; (1): 17-20. (in Russian) (pdf)
31. Garbuzenko D.V. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis]. Ter. Arkh. 2014; 86 (2): 90-95. (in Russian) (pdf) (PubMed)
32. Garbuzenko D.V. [Ectopic varicosis: a rare case of gastrointestinal hemorrhage]. Klin. Med. (Mosk). 2014; 92 (6): 12-21. (in Russian) (pdf) (PubMed)
33. Garbuzenko D.V. [Non-invasive assessment of portal hypertension in patients with liver cirrhosis]. Poliklinika 2015; (2): 33-39. (in Russian) (pdf)
34. Garbuzenko D.V. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World J. Gastroenterol. 2015; 21 (20): 6117-6126. (pdf) (PubMed)
35. Garbuzenko D.V. Treatment of acute esophageal variceal bleeding in cirrhotic patients. Abdomen 2015; 2: e958.  (pdf)
36. Garbuzenko D.V., Bordunovskii V.N. The Effect of Laser Revascularization of the Liver on Portal Hemodynamics in Cirrhotic Patients: Preliminary Study. Gastroenterol Hepatol Open Access 2015; 2 (6): 00060. (pdf)
37. Garbuzenko D.V. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding. Curr Med Res Opin. 2016; 32 (3): 467-475. (pdf) (PubMed)
38. Garbuzenko D.V. [Aspects of pathogenetic pharmacotherapy for portal hypertension in liver cirrhosis]. Ter. Arkh. 2016; 88 (2): 101-108. (in Russian) (pdf) (PubMed)
39. Garbuzenko D.V., Arefyev N.O., Belov D.V. Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis. World J. Hepatol. 2016; 8 (16): 665-672, (pdf) (PubMed)
40. Ivashkin V.T., Mayevskaya M.V., Pavlov Ch.S., Fedosyina Ye.A., Bessonova Ye.N.,  Pirogova I.Yu., Garbuzenko D.V. [Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2016; 26 (4): 71-102. (in Russian) (pdf)
41. Garbuzenko D.V. [The principles of primary prevention of bleeding from esophageal varices in patients with liver cirrhosis]. Klin. Med. (Mosk). 2016; 94 (7): 503-509. (in Russian) (pdf) (PubMed) 
42. Garbuzenko D.V., Arefyev N.O., Belov D.V. Restructuring of the vascular bed in response to hemodynamic disturbances in portal hypertension. World J. Hepatol. 2016; 8 (36): 1602-1609. (pdf) (PubMed)
43. Arefyev N.O., Garbuzenko D.V., Khasanov L.R. Choosing an Optimal Suture Material for Prehepatic Portal Hypertension Modeling. Int. J. Clin. Exp. Med. Sci. 2016; 2 (6): 117-121. (pdf) 
44. Arefyev N.O., Garbuzenko D.V., Emelyanov I.V., Khasanov L.R., Mineeva L.V. Changes in the microvasculature of small bowel mesentery in rats with prehepatic portal Hypertension: the preliminary study in vivo. Abdomen 2017; 4: e1580. (pdf)
45. Garbuzenko D.V. [The principles of management of patients with liver cirrhosis comlicated by ascites]. Klin. Med. (Mosk). 2017; 95 (9): 789-796. (in Russian) (pdf) 
46. Garbuzenko D.V., Arefyev N.O. Hepatic hydrothorax: An update and review of the literature. World J. Hepatol. 2017; 9 (31): 1197-1204. (pdf) (PubMed)
47. Arefyev N.O., Garbuzenko D.V., Kazachkov E.L., Bordunovskii V.N. [Portal hypertension associated angiogenesis assay in experimental studies (literature review)]. Ural. Med. Zhurn. 2018; (2): 16-23. (in Russian) (pdf)
48. Arefyev N.O., Garbuzenko D.V., Kazachkov E.L. Modern Methods for Studying Portal Hypertension Associated Angiogenesis in Experimental Research. Eur. Med. J. 2018; 3 (2): 90-99. (pdf)
49. Garbuzenko D.V., Belov D.V., Arefyev N.O. A rare case of internal small intestinal strangulation. General Surgery: Open Access. 2018; 1 (1): 3-4. (pdf)
50. Garbuzenko D.V., Arefyev N.O., Kazachkov E.L. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol. 2018; 24 (33): 3738-3748. (pdf) (PubMed) 
51. Belov D.V., Garbuzenko D.V., Fokin A.A., Milievskaya E.B. [Risk factors of abdominal complications after coronary artery bypass grafting]. Byulleten' NTSSSKH im. A.N. Bakuleva RAMN «Serdechno-sosudistyye zabolevaniya». 2018; 19 (6): 794-799. (in Russian) (pdf)
52. Garbuzenko D.V. [Hydrothorax in liver disease: pathogenesis, diagnosis, treatment]. Klin. Med. (Mosk). 2018; 96 (7): 604-611 (in Russian) (pdf)
53. Garbuzenko D.V.,  Belov D.V., Arefyev N.O. A rare complication of cardiac surgery: Ogilvie syndrome. J Postgrad Med. 2019; 65 (1): 56-57. (pdf) (PubMed)
54. Belov D.V., Garbuzenko D.V., Milievskaya E.B., Bordunovskiy V.N. [Early abdominal complications after coronary artery bypass surgery with cardiopulmonary bypass: diagnosis and treatment]. Byulleten' NTSSSKH im. A.N. Bakuleva RAMN «Serdechno-sosudistyye zabolevaniya». 2019; 20 (4): 305-312. (in Russian) (pdf) 
55. Garbuzenko D.V., Arefyev N.O., Kazachkov E.L. Angiogenesis and Portal Hypertension: An Update. In: Anti-Angiogenesis Drug Discovery and Development. Vol. 4. Ed. Atta-ur-Rahman and M. Iqbal Choudhary. Sharjah, UAE: Bentham Science Publishers; 2019. p. 162-218. (pdf) 
56. Belov D.V., Garbuzenko D.V., Fokin A.A., Naymushina Yu.V., Milievskaya E.B., Lukin O.P., Peshikov O.V. [А prognostic scale for the prediction of early abdominal copmplications after coronary artery bypass surgery with cardiopulmonary bypass]. Russian Journal of Thoracic and Cardiovascular Surgery. 2019; 61 (3): 190–196. (in Russian) (pdf)
57. Garbuzenko D.V., Arefyev N.O. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol. 2019; 25 (28): 3738-3752. (pdf) (PubMed)
58. Garbuzenko D.V., Belov D.V., Fokin A.A., Milievskaya E.B. [Acute pancreatitis after cardiac surgery with cardiopulmonary bypass]. Russian Journal of Thoracic and Cardiovascular Surgery. 2019; 61 (5): 415-422. (in Russian) (pdf)
59. Belov D.V., Garbuzenko D.V., Lukin O.P., Anufrieva S.S. [Role of laboratory methods in integrated diagnostics of acute mesenterial ischemia]. Medical Journal of the Russian Federation. 2019; 25 (5-6): 316-323. (in Russian) (pdf)
60. Belov D.V., Moskalev V.I., Garbuzenko D.V., Arefyev N.O. Left atrial appendage aneurysm: A case report. World J. Clin. Cases. 2020; 8 (19): 4443-4449. (pdf) (PubMed)
61. Belov D.V., Garbuzenko D.V., Abramovskikh K.A., Arefyev N.O. Risk score for predicting abdominal complications after coronary artery bypass grafting. World J. Cardiol. 2020; 12 (10): 492-500. (pdf) (PubMed)
62. Garbuzenko D.V., Arefyev N.O. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. J. Evid. Based Med. 2020; 13 (4): 313-324. (pdf) (PubMed)
63. Belov D.V., Garbuzenko D.V., Naymushina Yu.V., Lukin O.P., Milievskaya E.B., Leontiev S.N., Mezentsev V.I. [Prognostic scale for the prediction of early abdominal complications after correction of heart diseases with cardiopulmonary bypass]. Russian Journal of Thoracic and Cardiovascular Surgery. 2020; 5 (62): 426-431. (in Russian) (pdf)
64. Belov D.V., Garbuzenko D.V., Lukin O.P., Anufrieva S.S. [Heyde’s syndrome as a rare cause of gastrointestinal bleeding in aortic stenosis patients]. Cardiovascular Therapy and Prevention. 2021; 20 (1): 59-64. (in Russian) (pdf)
65. Belov D.V., Garbuzenko D.V., Anufrieva S.S. [A rare case of gerniation and incarceration of the gallbladder]. Khirurgiia (Mosk). 2021; (10): 110-112. (in Russian) (pdf) (PubMed)
66. Garbuzenko D.V. [The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection]. Problems of Virology. 2021; 66 (5): 331-339. (in Russian) (pdf) (PubMed)
67. Garbuzenko D.V., Belov D.V. [Non-alcoholic fatty liver disease as an independent factor of cardiometabolic risk of cardiovascular diseases]. Experimental and Clinical Gastroenterology. 2021; 194 (10): 22–34. (in Russian) (pdf)
68. Belov D.V., Garbuzenko D.V., Andrievskikh S.I., Anufrieva S.S. [Aorto-digestive fistula: a rare cause of gastrointestinal bleeding]. Circulation Pathology and Cardiac Surgery. 2021; 25 (4): 23-29. (in Russian) (pdf)
69. Garbuzenko D.V. [Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2021; 31 (5): 16-24. (in Russian) (pdf)
70. Garbuzenko D.V. [Non-invasive diagnosis of liver fibrosis associated with nonalcoholic steatohepatitis]. Russian Journal of Evidence-based Gastroenterology. 2021; 10 (4): 75–81. (in Russian) (pdf)
71. Garbuzenko D.V. [Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infection]. Medical Journal of the Russian Federation. 2021; 27 (4): 373-384. (in Russian) (pdf)
72. Garbuzenko D.V. [Molecular stimuli of fibrogenic activation in hepatic stellate cells]. Pathological Physiology and Experimental Therapy, Russian Journal. 2022; 66 (1): 112–119. (in Russian) (pdf)
73. Garbuzenko D.V. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis. World J. Clin. Cases. 2022; 10 (12): 3662-3676. (pdf) (PubMed)
74. Garbuzenko D.V. [Mechanisms and Clinical Significance of Hepatic Fibrogenesis in Iron Overload]. Doctor.Ru. 2022; 21 (2): 23–29. (in Russian) (pdf)
75. Garbuzenko D.V. [Principles of diagnosis and treatment of alcohol-induced liver fibrosis]. Meditsinskiy Sovet. 2022; 16 (7): 104–114. (in Russian) (pdf)
76. Belov D.V., Naimushina Yu.V., Fokin A.A., Garbuzenko D.V., Leontiev S.N., Mezentsev V.I., Tabashnikova S.V., Semagin A.A. [The role of transesophageal echocardiography in gastrointestinal bleeding]. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2022; 15 (3): 270‑276. (in Russian) (pdf)
77. Garbuzenko D.V. Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease. Gastroenterol. Hepatol. Bed Bench. 2022; 15 (3): 194-203. (pdf) (PubMed)
78. Garbuzenko D.V. Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis. The Russian Archives of Internal Medicine. 2022; 12 (5): 352-362. (pdf)
79. Garbuzenko D.V. Current strategies for targeted therapy of liver fibrosis. Bulletin of Siberian Medicine. 2022; 21 (3): 154–165. (pdf)
80. Garbuzenko D.V., Belov D.V., Kosharnova A.L., Anufrieva S.S., Danko N.A. [Gallbladder herniation as a Rare Complication of Abdominal Drainage]. Novosti Khirurgii. 2022; 30 (3): 317-321. (in Russian) (pdf)
81. Garbuzenko D.V. [Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential]. Russian Journal of Evidence-based Gastroenterology. 2022; 11 (4): 65–76. (in Russian) (pdf)
82. Garbuzenko D.V., Belov D.V. Herniation and incarceration of the gallbladder through the abdominal drain site: A case report. Int. J. Abdom. Wall Hernia Surg. 2023; 6 (1): 53-55. (pdf)
83. Garbuzenko D.V. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis. World J. Hepatol. 2023; 15 (4): 525-537. (pdf) (PubMed)
84. Garbuzenko D.V. Contemporary concepts of prevention and management of gastroesophageal variceal bleeding in liver cirrhosis patients. World J. Hepatol. 2024; 16 (2): 126-134. (pdf) (PubMed)
85. Garbuzenko D.V. Mechanisms of epigenetic regulation in the fibrogenic activation of hepatic stellate cells in non-alcoholic fatty liver disease. Gene Expr. 2024; 23 (1): 31–43. (pdf) (PubMed)
86. Garbuzenko D.V. Liver fibrosis as an independent cardiovascular risk factor in non-alcoholic fatty liver disease. J. Transl. Gastroenterol. 2024; 2 (1): 21–29. (pdf)
87. Garbuzenko D.V. Milestones to optimize of transjugular intrahepatic portosystemic shunt technique as a method for the treatment of portal hypertension complications. World J. Hepatol. 2024; 16 (6): 891-899. (pdf) (PubMed)
88. Garbuzenko D.V. Current approaches to the management of jejunal variceal bleeding at the site of hepaticojejunostomy after pancreaticoduodenectomy. World J. Gastroenterol. 2024; 30 (37): 4083-4086. (pdf) (PubMed)
89. Garbuzenko D.V. Optimization stages of transjugular intrahepatic portosystemic shunt technique as a treatment  method for portal hypertension complications. Annals of HPB surgery. 2024; 29 (3): 116–123. (in Russian) (pdf)